You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR BELATACEPT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for belatacept

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00035555 ↗ Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney Completed Bristol-Myers Squibb Phase 2 2001-03-01 The purpose of this study is to determine whether treatment with Belatacept (BMS-224818) is as efficacious as treatment with cyclosporine at preventing acute rejection and with a superior safety/tolerability profile (better kidney function and blood pressure, fewer lipid problems, less diabetes mellitus).
NCT00114777 ↗ Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant Completed Bristol-Myers Squibb Phase 3 2005-02-01 The purpose of this trial is to learn if Belatacept is effective and safe as a first line of immunosuppression treatment in patients undergoing a renal transplant where the donor kidney is obtained in patients with extended criteria.
NCT00256750 ↗ Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) Completed Bristol-Myers Squibb Phase 3 2005-03-01 The purpose of this study is to learn if Belatacept can provide protection from organ rejection following kidney transplantation while avoiding some of the toxic effects of standard immunosuppressive medications such as kidney damage. Effects on kidney function and patient survival as well as drug safety will also be studied.
NCT00276250 ↗ Islet Transplantation Using Abatacept Completed Juvenile Diabetes Research Foundation Phase 2 2005-12-01 Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.
NCT00276250 ↗ Islet Transplantation Using Abatacept Completed Emory University Phase 2 2005-12-01 Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for belatacept

Condition Name

Condition Name for belatacept
Intervention Trials
Kidney Transplantation 15
Renal Transplantation 8
Renal Transplant 3
Chronic Kidney Failure 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for belatacept
Intervention Trials
Kidney Failure, Chronic 8
Renal Insufficiency 6
Delayed Graft Function 4
Diabetes Mellitus, Type 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for belatacept

Trials by Country

Trials by Country for belatacept
Location Trials
United States 266
Canada 21
Argentina 19
Brazil 15
France 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for belatacept
Location Trials
California 23
Georgia 21
North Carolina 16
New York 13
Massachusetts 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for belatacept

Clinical Trial Phase

Clinical Trial Phase for belatacept
Clinical Trial Phase Trials
Phase 4 14
Phase 3 8
Phase 2 28
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for belatacept
Clinical Trial Phase Trials
Completed 28
Not yet recruiting 10
Recruiting 9
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for belatacept

Sponsor Name

Sponsor Name for belatacept
Sponsor Trials
Bristol-Myers Squibb 37
National Institute of Allergy and Infectious Diseases (NIAID) 8
Clinical Trials in Organ Transplantation 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for belatacept
Sponsor Trials
Other 56
Industry 50
NIH 9
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.